Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials

The conduct of clinical trials in colorectal cancer has historically relied upon endpoints such as disease-free (DFS) or overall survival (OS). While ideal, these endpoints require long-term follow-up, thus contributing to a slow pace of scientific progress in clinical research. Identification of sh...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Thomas J., Allegra, Carmen J., Yothers, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Localized Colorectal Cancer (RD Kim, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550644/
https://www.ncbi.nlm.nih.gov/pubmed/26321890
http://dx.doi.org/10.1007/s11888-015-0285-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550644/
https://www.ncbi.nlm.nih.gov/pubmed/26321890
http://dx.doi.org/10.1007/s11888-015-0285-2

Ejemplares similares